Search filters

List of works by Sith Sathornsumetee

AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma

scientific article published on September 2006

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

scientific article published on November 2008

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

scientific article published in October 2007

Chemotherapy and novel therapeutic approaches in malignant glioma

scientific article

Effect of spinal tap test on the performance of sit-to-stand, walking, and turning in patients with idiopathic normal pressure hydrocephalus.

scientific article

Malignant glioma drug discovery – targeting protein kinases

scientific article published on January 1, 2007

Molecularly targeted therapy in neuro-oncology

scientific article published on January 1, 2012

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

scientific article

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma

scientific article published on 10 March 2012

Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma

scientific article

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

scientific article

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

scientific article published in October 2005

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

scientific article

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

scientific article

Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas

scientific article

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

scientific article

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

scientific article

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

scientific article published in February 2007

SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.

scientific article

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma

scientific article published on 21 March 2008

Therapeutic strategies to target multiple kinases in glioblastoma

scientific article published on October 1, 2011

Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan

scientific article published on January 2008

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors

scientific article published on November 2005